Mark Buzza

1.2k total citations
16 papers, 553 citations indexed

About

Mark Buzza is a scholar working on Hematology, Immunology and Allergy and Nephrology. According to data from OpenAlex, Mark Buzza has authored 16 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Immunology and Allergy and 3 papers in Nephrology. Recurrent topics in Mark Buzza's work include Cell Adhesion Molecules Research (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Blood donation and transfusion practices (3 papers). Mark Buzza is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Blood donation and transfusion practices (3 papers). Mark Buzza collaborates with scholars based in Australia, United States and Canada. Mark Buzza's co-authors include Judy Savige, Hayat Dagher, Kesha Rana, D. J. Wilson, Yan Yan Wang, Stephen Tonna, Timothy Colin Bednall, Barbara Masser, Liliana L. Bove and Jeffrey J. Babon and has published in prestigious journals such as Journal of Clinical Oncology, Kidney International and American Journal of Kidney Diseases.

In The Last Decade

Mark Buzza

15 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Buzza Australia 12 240 213 163 101 101 16 553
Víctor Martínez Spain 10 112 0.5× 52 0.2× 132 0.8× 23 0.2× 25 528
José Antonio López Spain 6 17 0.1× 80 0.4× 153 0.9× 1 0.0× 15 0.1× 11 844
Philip S. Klein United States 7 242 1.0× 12 0.1× 66 0.4× 1 0.0× 16 0.2× 18 489
S Gentili Italy 10 19 0.1× 2 0.0× 154 0.9× 9 0.1× 33 0.3× 16 685
Seung Won Choi South Korea 11 38 0.2× 11 0.1× 33 0.2× 27 0.3× 40 373
Jeremy P. Wood United States 13 6 0.0× 17 0.1× 110 0.7× 2 0.0× 13 0.1× 35 804
Andrea Blake Australia 6 11 0.0× 8 0.0× 36 0.2× 7 0.1× 4 0.0× 22 393
Kelley A. Barney United States 4 4 0.0× 29 0.1× 104 0.6× 9 0.1× 5 479
Güldane Cengiz Seval Türkiye 11 7 0.0× 1 0.0× 144 0.9× 36 0.4× 74 0.7× 59 411
G. P. Summerfield United Kingdom 11 43 0.2× 1 0.0× 32 0.2× 4 0.0× 28 0.3× 21 304

Countries citing papers authored by Mark Buzza

Since Specialization
Citations

This map shows the geographic impact of Mark Buzza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Buzza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Buzza more than expected).

Fields of papers citing papers by Mark Buzza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Buzza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Buzza. The network helps show where Mark Buzza may publish in the future.

Co-authorship network of co-authors of Mark Buzza

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Buzza. A scholar is included among the top collaborators of Mark Buzza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Buzza. Mark Buzza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Collins, Ian, John E. McDonough, Mark Buzza, et al.. (2025). Development of a virtual multidisciplinary meeting framework for less common cancers. Internal Medicine Journal. 55(2). 313–315.
2.
Best, Stephanie, Karin Thursky, Mark Buzza, et al.. (2024). Aligning organisational priorities and implementation science for cancer research. BMC Health Services Research. 24(1). 338–338. 3 indexed citations
3.
Underhill, Craig, et al.. (2024). Decentralized Clinical Trials as a New Paradigm of Trial Delivery to Improve Equity of Access. JAMA Oncology. 10(4). 526–526. 12 indexed citations
4.
Hsiao, Sarah, Seanna Davidson, Peter L. Choyke, et al.. (2020). The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs. Nature Reviews Urology. 17(9). 499–512. 15 indexed citations
5.
Saad, Fred, Stacey A. Kenfield, June M. Chan, et al.. (2016). Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL – MCRPC): A Movember funded multicenter, randomized, controlled phase III study.. Journal of Clinical Oncology. 34(15_suppl). TPS5092–TPS5092. 4 indexed citations
6.
7.
Bagot, Kathleen L., Liliana L. Bove, Barbara Masser, Timothy Colin Bednall, & Mark Buzza. (2012). Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment. Transfusion. 53(5). 1108–1119. 43 indexed citations
8.
Bove, Liliana L., Timothy Colin Bednall, Barbara Masser, & Mark Buzza. (2011). Understanding the plasmapheresis donor in a voluntary, nonremunerated environment. Transfusion. 51(11). 2411–2424. 51 indexed citations
9.
Rana, Kesha, Yan Yan Wang, Harley R. Powell, et al.. (2005). Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. Pediatric Nephrology. 20(12). 1729–1737. 13 indexed citations
10.
Buzza, Mark, Hayat Dagher, D. J. Wilson, et al.. (2003). Mutations in the COL4A4 gene in thin basement membrane disease. Kidney International. 63(2). 447–453. 54 indexed citations
11.
Rana, Kesha, Nicole M. Isbel, Mark Buzza, et al.. (2003). Clinical, histopathologic, and genetic studies in nine families with focal segmental glomerulosclerosis. American Journal of Kidney Diseases. 41(6). 1170–1178. 11 indexed citations
12.
Savige, Judy, Kesha Rana, Stephen Tonna, et al.. (2003). Thin basement membrane nephropathy. Kidney International. 64(4). 1169–1178. 165 indexed citations
13.
Buzza, Mark, D. J. Wilson, & Judy Savige. (2001). Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome. Kidney International. 59(5). 1670–1676. 54 indexed citations
14.
15.
Dagher, Hayat, Mark Buzza, Deb Colville, et al.. (2001). A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome. American Journal of Kidney Diseases. 38(6). 1217–1228. 47 indexed citations
16.
Buzza, Mark, Hayat Dagher, Jeffrey J. Babon, et al.. (2001). COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome11See Editorial by Monnens, p. 799. Kidney International. 60(2). 480–483. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Víctor Martínez Breakdown of academic impact, for papers by José Antonio López Breakdown of academic impact, for papers by Philip S. Klein Breakdown of academic impact, for papers by S Gentili Breakdown of academic impact, for papers by Seung Won Choi Breakdown of academic impact, for papers by Jeremy P. Wood Breakdown of academic impact, for papers by Andrea Blake Breakdown of academic impact, for papers by Kelley A. Barney Breakdown of academic impact, for papers by Güldane Cengiz Seval Breakdown of academic impact, for papers by G. P. Summerfield
Rankless by CCL
2026